Automation In BiopharmaA strong shift towards automation among biopharma customers is expected, with Growth Direct systems providing significant cost savings by replacing 2-3 full-time employees.
Growth DriversManagement noted key FY26 growth drivers including a strong sales funnel featuring multiple multi-system rollouts, MilliporeSigma having purchase commitments beginning in FY26, durable consumables and service growth as the installed base grows, and a strong competitive positioning to benefit from the US onshoring of biopharma manufacturing.
Market LeadershipRapid Micro Biosystems is emerging as the category leader in microbial quality control automation with its Growth Direct platform, a system that compresses testing timelines from weeks to days, reduces contamination risk, and ensures compliance with increasingly strict regulatory requirements.